Franklin Genomic Advancements Etf (HELX) Technical Analysis

$30.56▲-1.58%

Market is closed - opens 8 PM, 06 Dec 2024

Insights

Franklin Genomic Advancements Etf is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Based on analysis of the Oscillators technical indicator, the current market trend for Franklin Genomic Advancements Etf stock suggests that it is range bound and no decision can be made based on this information
Based on analysis of the Moving Averages technical indicator, Franklin Genomic Advancements Etf stock is in a downtrend↘️
Based on analysis of the Pivot Points, the current market trend for Franklin Genomic Advancements Etf stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name	Value	Action
Relative Strength Index	55.87	Neutral
Stochastic	94.11, 81.25	Neutral
Ultimate Oscillator	70.29	Sell
Stochastic Relative Strength Index	100.0, 97.72	Neutral
Moving Average Convergence Divergence	-0.15, -0.37	Neutral

Moving Averages

Simple Moving Average

Period (Days)	Value	Action
10	29.99	Sell
20	30.35	Sell
50	31.16	Sell

Exponential Moving Average

Period (Days)	Value	Action
10	30.44	Sell
20	30.45	Sell
50	31.01	Sell

Volume Weighted Moving Average

Period (Days)	Value	Action
10	30.02	Neutral
20	30.29	Neutral
50	30.82	Neutral

Double Exponential Moving Average

Period (Days)	Value	Action
10	30.68	Buy
20	30.16	Sell
50	30.25	Sell

Triple Exponential Moving Average

Period (Days)	Value	Action
10	31.05	Buy
20	30.4	Buy
50	29.87	Sell

Pivot

Pivot	Value
Resistance L3	31.16
Resistance L2	31.13
Resistance L1	31.07
Pivot Point	31.04
Support L1	30.98
Support L2	30.95
Support L3	30.89

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.